Free shipping starts now, no minimum, no coupons required!

Anti-BDNF Antibody

Brain-derived neurotrophic factor

Cat #: ANT-010
Alternative Name Brain-derived neurotrophic factor
  • KO Validated
  • Lyophilized Powder yes
    Type: Polyclonal
    Host: Rabbit
    Reactivity: h, m, r
    • Peptide (C)VLEKVPVSKGQLK, corresponding to amino acid residues 166-178 of human BDNF (precursor) (Accession P23560).
    Accession (Uniprot) Number P23560
    Gene ID 627
    Peptide confirmation Confirmed by amino acid analysis and mass spectrometry.
    Homology Mouse, rat and many other species - identical.
    RRID AB_2039756.
    Purity Affinity purified on immobilized antigen.
    Form Lyophilized powder. Reconstituted antibody contains phosphate buffered saline (PBS), pH 7.4, 1% BSA, 0.05% NaN3.
    Isotype Rabbit IgG.
    Specificity The antibody is specific for BDNF; it does not crossreact with NGF, NT-3 or NT-4.
    Storage before reconstitution The antibody ships as a lyophilized powder at room temperature. Upon arrival, it should be stored at -20°C.
    Reconstitution 25 μl, 50 μl or 0.2 ml double distilled water (DDW), depending on the sample size.
    Antibody concentration after reconstitution 0.72 mg/ml.
    Storage after reconstitution The reconstituted solution can be stored at 4°C for up to 1 week. For longer periods, small aliquots should be stored at -20°C. Avoid multiple freezing and thawing. Centrifuge all antibody preparations before use (10000 x g 5 min).
    Standard quality control of each lot Western blot analysis.
    Applications: ic, if, ih, wb
    May also work in: ifc*, ip*
    Western blot
    • Expression of BDNF in mouse cerebellum
      Expression of BDNF in mouse cerebellum
      Immunohistochemical staining of mouse cerebellum with Anti-BDNF Antibody (#ANT-010). A. BDNF (red) appears in Purkinje cells (upward pointing arrows) and is distributed diffusely in the molecular layer (Mol) including in astrocytic fibers (downward pointing arrows). B. Staining of astrocytic fibers with glial fibrillary acidic protein (green) in the same section demonstrates the distribution of BDNF to neuronal as well as to astrocytic cellular components. C. Confocal merge of BDNF and GFAP.
    • Multiplex staining of Kir6.2 and BDNF in mouse hippocampus.
      Multiplex staining of Kir6.2 and BDNF in mouse hippocampus.
      Immunohistochemical staining of immersion-fixed, free floating mouse brain frozen sections using Guinea pig Anti-Kir6.2 Antibody (#APC-020-GP), (1:300) and Anti-BDNF Antibody (#ANT-010), (1:300). A. Kir6.2 staining (red) appears in the dentate gyrus granule layer (G) and in hilar interneurons (arrows). B. BDNF staining (green) in the same section appears in the dentate gyrus granule layer (G) and in hilar interneurons (arrows). C. Merge of the two images reveals colocalization of Kir6.2 and BDNF in hippocampal interneurons.
    • BDNF transfected striatal cells (1:50) (del Toro, D. et al.(2006) J. Neurosci. 26, 12748.).
    1. Chao, M.V. (2003) Nature Rev. Neurosci. 4, 299.
    2. Blum, R. and Konnerth, A. (2005) Physiology 20, 70.
    3. Kalb, R. (2005) Trends Neurosci. 28, 5.
    4. Lu, B. et al. (2005) Nature Rev. Neurosci. 6, 603.
    Scientific background

    Brain-derived neurotrophic factor (BDNF) is a member of the neurotrophin family of growth factors which includes nerve growth factor (NGF), neurotrophin-3 (NT-3) and neurotrophin-4/5 (NT-4/5).

    All neurotrophins are synthesized as preproneurotrophin precursors that are subsequently processed within the intracellular transport pathway to yield proneurotrophins that are further processed to generate the mature form. The mature form of BDNF is a non-covalent stable homodimer that can be secreted in both constitutive and regulated pathways.

    BDNF conveys its activity by binding to two classes of receptors, a member of the Trk receptor tyrosine kinase family (TrkB) and the pan-neurotrophin receptor p75NTR. Binding of BDNF to the TrkB receptor triggers ligand-induced dimerization and autophosphorylation of tyrosine residues. This activates various signaling cascades such the MAPK, PI3K and PLCγ pathways that are involved in cell growth, survival and differentiation of neurons in the central and peripheral nervous system.

    Interestingly, recent evidence suggests that BDNF may influence target cell function via ion channel modulation. Ion channel activity in the target cells can be modulated by a TrkB-mediated mechanism that has not yet been determined. BDNF is able to block both KV1.3 and AMPA-subtype glutamate ion channel currents in sensory neurons, while it can induce activation of the TRPC3 cation channel in neurons and of the NaV1.9 Na+ channel in hippocampal neurons. These newly recognized BDNF actions underlie its “rapid” neuronal functions that include changes in neuronal excitability, plasticity and synaptic transmission.

    Application key:

    CBE- Cell-based ELISA, FC- Flow cytometry, ICC- Immunocytochemistry, IE- Indirect ELISA, IF- Immunofluorescence, IFC- Indirect flow cytometry, IHC- Immunohistochemistry, IP- Immunoprecipitation, LCI- Live cell imaging, N- Neutralization, WB- Western blot

    Species reactivity key:

    H- Human, M- Mouse, R- Rat
    Image & Title:

    Anti-BDNF Antibody
    Expresssion of BDNF in mouse brain
    Immunohistochemical staining of mouse brain sections using Anti-BDNF Antibody (#ANT-010). BDNF staining (purple) is expressed in astrocytes and co-localizes with GFAP (blue) but not with neurofilament-1 (NF-L), (green).Adapted from Fulmer, C.G. et al. (2014) J. Neurosci. 34, 8186. with permission of the Society for Neuroscience.

    Last update: 08/01/2023

    Anti-BDNF Antibody (#ANT-010) is a highly specific antibody directed against an epitope of the human protein. The antibody can be used in western blot, immunocytochemistry, and immunohistochemistry applications. It has been designed to recognize BDNF from rat, human, and mouse samples. The antibody is specific for BDNF; it does not crossreact with NGF, NT-3 or NT-4.

    For research purposes only, not for human use



    KO validation citations
    1. Immunohistochemical staining of mouse nucleus of the solitary tract sections. Tested in inducible BDNF-knockout mice.
      Sunc, C. et al. (2018) J. Neurosci. 38, 6873.
    2. Immunohistochemical staining of rat brain sections. Tested in shBDNF-treated rats.
      Taliaz, D. et al. (2010) Mol Psychiatry 15, 80.
    Western blot citations
    1. Mouse brain lysate (1:200).
      Nguyen, L. et al. (2016) Neuroreport 27, 1004.
    2. Rat brain lysate (1:1000).
      Hovens, I.B. et al. (2015) Am. J. Physiol. 309, R148.
    3. Mouse brain lysate (1:200).
      Duarte-Neves, J. et al. (2015) Hum. Mol. Genet. 24, 5451.
    4. Human SH-SY5Y and rat primary cortical neuron lysates (1:1000).
      Shin, M.K. et al. (2014) Neuropharmacology 77, 414.
    5. Mouse brain lysate (1:2000).
      Shin, M.K. et al. (2014) Neurobiol. Aging. 35, 990.
    6. Rat lamina terminalis lysate (1:200).
      Clayton, S.C. et al. (2014) Am. J. Physiol. 306, R908.
    7. Rat brain lysates (1:500).
      Tian, X. et al. (2013) PLoS ONE 8, e69252.
    Immunohistochemistry citations
    1. Mouse nucleus of the solitary tract sections. Also tested in inducible BDNF-knockout mice.
      Sunc, C. et al. (2018) J. Neurosci. 38, 6873.
    2. Mouse retina sections (1:200).
      Benhar, I. et al. (2016) EMBO J. 35, 1219.
    3. Mouse brain sections (1:200).
      Wattananit, S. et al. (2016) J. Neurosci. 36, 4182.
    4. Rat brain sections (8 µg/ml).
      Louveau, A. et al. (2015) Glia 63, 2298.
    5. Mouse brain sections.
      Fulmer, C.G. et al. (2014) J. Neurosci. 34, 8186.
    6. Rat brain sections. Also tested in shBDNF-treated rats.
      Taliaz, D. et al. (2010) Mol Psychiatry 15, 80.
    Immunocytochemistry citations
    1. BDNF transfected striatal cells (1:50).
      Del Toro, D. et al. (2006) J. Neurosci. 26, 12748.
    More product citations
    1. Demel, C. et al. (2011) J. Neuroinflammation. 8, 7.
    2. Poblete-Naredo, I. et al. (2011) Neurochem. Int. 59, 1133.
    3. España, J. et al. (2010) J. Neurosci. 30, 9402.
    4. Kong, Li. et al. (2010) Neurobiol. Dis. 38, 446.
    5. Taliaz, D. et al. (2010) Mol Psychiatry 15, 80.
    6. Lewitus, G.M. et al. (2008) Brain Behav. Immun. 22, 1108.
    7. Fiszman, M.L. et al. (2005) J. Neurosci. 25, 2024.


    Scientific Background

    Shipping and Ordering information